Table 4 of
Brzović-Šarić, Mol Vis 2015; 21:649-664. Table 4 of
Brzović-Šarić, Mol Vis 2015; 21:649-664.
Table 4. Correlation analysis of measured parameters in vitreous and serum of non-diabetic patients with eye disorders (NDED) patients.
| Vitreous | Serum | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | VEGF (pg/l) | AOPP (µM) | LPO (µM) | MDA (nmol/ml) | SOD (U/ml) | GSH (µmol/ml) | VEGF (pg/l) | AOPP (µM) | LPO (µM) | MDA (nmol/ml) | SOD (U/ml) | GSH (µmol/ml) |
| Vitreous | ||||||||||||
| VEGF (pg/l) | / | -0.047 | 0.161 | 0.007 | -0.121 | -0.151 | 0.234 | -0.017 | 0.097 | -0.119 | -0.027 | 0.022 |
| AOPP (µM) | 0.807 | / | 0.053 | -0.141 | 0.075 | 0.058 | -0.221 | 0.048 | 0.114 | -0.122 | -0.052 | -0.092 |
| LPO (µM) | 0.269 | 0.781 | / | 0.176 | 0.045 | 0.017 | -0.073 | -0.199 | 0.215 | -0.046 | 0.168 | -0.201 |
| MDA (nmol/ml) | 0.971 | 0.487 | 0.369 | / | -0.032 | -0.131 | -0.326 | 0.296 | -0.029 | -0.257 | 0.105 | 0.012 |
| SOD (U/ml) | 0.433 | 0.704 | 0.767 | 0.876 | / | -0.058 | 0.021 | -0.096 | 0.137 | 0.126 | 0.104 | -0.239 |
| GSH (µmol/ml) | 0.309 | 0.763 | 0.909 | 0.508 | 0.702 | / | -0.048 | 0.089 | -0.001 | 0.021 | 0.336 | -0.244 |
| Serum | ||||||||||||
| VEGF (pg/l) | 0.105 | 0.242 | 0.621 | 0.091 | 0.892 | 0.748 | / | 0.023 | 0.111 | -0.124 | -0.072 | 0.077 |
| AOPP (µM) | 0.927 | 0.801 | 0.284 | 0.126 | 0.622 | 0.635 | 0.903 | / | 0.127 | -0.457 | 0.222 | 0.025 |
| LPO (µM) | 0.508 | 0.551 | 0.131 | 0.884 | 0.365 | 0.994 | 0.446 | 0.497 | / | 0.031 | 0.301 | -0.119 |
| MDA (nmol/ml) | 0.431 | 0.532 | 0.756 | 0.187 | 0.411 | 0.893 | 0.412 | 0.011 | 0.841 | / | 0.093 | -0.239 |
| SOD (U/ml) | 0.862 | 0.794 | 0.265 | 0.611 | 0.513 | 0.024 | 0.641 | 0.247 | 0.042 | 0.543 | / | -0.627# |
| GSH (µmol/ml) | 0.882 | 0.635 | 0.172 | 0.951 | 0.113 | 0.099 | 0.611 | 0.897 | 0.421 | 0.102 | <0.001 | / |